Manulife Financial Corporation vs Viatris Inc — how do they compare? Manulife Financial Corporation trades at $43.84 (market cap $73.19B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: Manulife Financial Corporation is far larger — about 3.9× Viatris Inc's market cap, and Manulife Financial Corporation pays the higher dividend (3.08%). Which is the better fit depends on your goals.
| MFC | VTRS | |
|---|---|---|
Market Cap | $73.19B | $18.69B |
Sector | Financials | Health |
52-Week High | $44.77 | $17.86 |
52-Week Low | $30.06 | $9.49 |
Enterprise Value | $68.35B | $30.81B |
Dividend Yield | 3.08% | 2.95% |
Trailing returns across standard periods
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →